Skip to content

A Registered Cohort Study on Wilson's Disease

A Registered Cohort Study on Wilson's Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04012658
Enrollment
2000
Registered
2019-07-09
Start date
2019-07-01
Completion date
2049-12-31
Last updated
2019-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wilson's Disease

Keywords

Wilson's Disease, Nature history, Genetics

Brief summary

The aim of this study is to determine the clinical spectrum and natural progression of Wilson's Disease in a prospective multicenter natural history study, to assess the clinical, genetic, epigenetic features and biomarkers of patients with Wilson's Disease to optimize clinical management.

Interventions

OTHERNo intervention

No intervention

Sponsors

Wan-Jin Chen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Patients with the genetic diagnosis of Wilson's Disease * Asymptomatic Wilson's Disease carriers * Relatives of Wilson's Disease patients or carriers * Unrelated healthy controls * Participants or Parent(s)/legal guardian(s) willing and able to complete the informed consent process

Exclusion criteria

\* Participants are unable to comply with study procedures and visit schedule

Design outcomes

Primary

MeasureTime frameDescription
The change of Unified Wilson's Disease Rating Scale (UWDRS)Up to 30yearsDisease severity will be assessed by application of the Unified Wilson's Disease Rating Scale (UWDRS), a clinical rating scale consists of three subscales. Higher UWDRS total scores indicate more severe disease.

Countries

China

Contacts

Primary ContactJin He, MD
hejinfjmu@hotmail.com86-0591-87982772
Backup ContactYi Lin, MD.PhD
linyi7811@163.com8613615039153

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026